Monopar Therapeutics (MNPR) Prepaid Assets (2016 - 2025)
Monopar Therapeutics (MNPR) reported Prepaid Assets of $63745.0 for Q4 2025, down 19.18% on a YoY basis from $78869.0 in Q4 2024, and down 84.63% sequentially from $414825.0 in Q3 2025.
Monopar Therapeutics (MNPR) Prepaid Assets (2016 - 2025) Analysis & Trends
Monopar Therapeutics (MNPR) has 10 years of Prepaid Assets data on file, last reported at $63745.0 in Q4 2025.
- For the quarter ending Q4 2025, Prepaid Assets fell 19.18% year-over-year to $63745.0; the trailing twelve-month figure through Dec 2025 stood at $63745.0 (down 19.18% YoY), and the FY2025 full-year result was $63745.0, down 19.18% from the prior year.
- Prepaid Assets fell to $63745.0 in Q4 2025, from $414825.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $523556.0 in Q1 2025 to a low of $45982.0 in Q4 2022.
- A 5-year average of $159167.5 and a median of $106809.5 in 2021 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets plunged 78.88% in 2022 and soared 736.85% in 2025, its largest moves.
- Tracing MNPR's Prepaid Assets over 5 years: stood at $217745.0 in 2021, then sank by 78.88% to $45982.0 in 2022, then jumped by 44.48% to $66433.0 in 2023, then rose by 18.72% to $78869.0 in 2024, then slipped by 19.18% to $63745.0 in 2025.
- Business Quant data shows MNPR's Prepaid Assets at $63745.0 in Q4 2025, $414825.0 in Q3 2025, and $497294.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,745.00 |
| Sep 30, 2025 | 414,825.00 |
| Jun 30, 2025 | 497,294.00 |
| Mar 31, 2025 | 523,556.00 |
| Dec 31, 2024 | 78,869.00 |
| Sep 30, 2024 | 49,570.00 |
| Jun 30, 2024 | 61,017.00 |
| Mar 31, 2024 | 118,987.00 |
| Dec 31, 2023 | 66,433.00 |
| Sep 30, 2023 | 73,193.00 |
| Jun 30, 2023 | 109,868.00 |
| Mar 31, 2023 | 106,819.00 |
| Dec 31, 2022 | 45,982.00 |
| Sep 30, 2022 | 55,700.00 |
| Jun 30, 2022 | 189,179.00 |
| Mar 31, 2022 | 193,635.00 |
| Dec 31, 2021 | 217,745.00 |
| Sep 30, 2021 | 106,800.00 |
| Jun 30, 2021 | 95,564.00 |
| Mar 31, 2021 | 114,569.00 |